{
  "id": "EvLn127",
  "type": "EvidenceLine",
  "evidenceItem": [
    {
      "id": "CritAssess376",
      "type": "CriterionAssessment",
      "criterion": {
        "id": "Crit309",
        "type": "Criterion",
        "label": "PM2",
        "description": "Absent from controls (or at extremely low frequency if recessive) (Table 6) in Exome Sequencing Project, 1000 Genomes Project, or Exome Aggregation Consortium",
        "defaultStrength": {
          "id": "EvLnStrgID143",
          "type": "EvidenceLineStrength",
          "label": "Pathogenic Moderate"
        },
        "comments": "Some groups are allowing to rule to be used if even not 100% absent\nFor instance, Cardio has allowed PM2 to be used if MAF is <0.05% with 95% CI if\nCI lower is ~0.00% (at 2 decimal places) AND CI upper is below 0.05%\n Caveat: Population data for insertions/deletions may be poorly called by next-generation sequencing"
      },
      "variant": {
        "id": "CanAll125",
        "type": "CanonicalAllele",
        "preferredCtxAllele": {
          "id": "CtxAll131",
          "type": "ContextualAllele",
          "relatedCanonicalAllele": "CanAll125",
          "alleleName": "NM_004333.4(BRAF):c.1447A>C (p.Lys483Gln)",
          "produces": [
            {
              "id": "CtxAll132",
              "type": "ContextualAllele",
              "relatedCanonicalAllele": "CanAll126",
              "alleleName": "NP_004324.2:p.Lys483Gln",
              "producedBy": "CtxAll131"
            }
          ]
        }
      },
      "outcome": {
        "id": "CritEvalID074",
        "type": "CriterionEvaluation",
        "label": "Met"
      },
      "evidenceLine": [
        {
          "id": "EvLn126",
          "type": "EvidenceLine",
          "evidenceItem": [
            {
              "id": "AllFreq101",
              "type": "AlleleFrequency",
              "ascertainment": {
                "id": "AscrtID203",
                "type": "Ascertainment",
                "label": "ExAc ascertainment method"
              },
              "population": {
                "id": "PopID093",
                "type": "Population",
                "label": "Combined"
              },
              "allele": {
                "id": "CanAll125",
                "type": "CanonicalAllele",
                "preferredCtxAllele": {
                  "id": "CtxAll131",
                  "type": "ContextualAllele",
                  "relatedCanonicalAllele": "CanAll125",
                  "alleleName": "NM_004333.4(BRAF):c.1447A>C (p.Lys483Gln)",
                  "produces": [
                    {
                      "id": "CtxAll132",
                      "type": "ContextualAllele",
                      "relatedCanonicalAllele": "CanAll126",
                      "alleleName": "NP_004324.2:p.Lys483Gln",
                      "producedBy": "CtxAll131"
                    }
                  ]
                }
              },
              "alleleCount": 0,
              "alleleFrequency": 0.0,
              "medianCoverage": 57.0
            }
          ]
        }
      ],
      "contribution": [
        {
          "type": "Contribution",
          "agent": {
            "id": "Agent010",
            "type": "Agent",
            "label": "ACME Molecular Lab"
          },
          "contributionDate": "6/11/2011 11:45 AM",
          "contributionRole": {
            "id": "ContribRoleID193",
            "type": "ContributoryRole",
            "label": "assessor role"
          }
        }
      ]
    }
  ],
  "evidenceStrength": {
    "id": "EvLnStrgID143",
    "type": "EvidenceLineStrength",
    "label": "Pathogenic Moderate"
  },
  "contribution": [
    {
      "type": "Contribution",
      "agent": {
        "id": "Agent010",
        "type": "Agent",
        "label": "ACME Molecular Lab"
      },
      "contributionDate": "6/11/2011 11:45 AM",
      "contributionRole": {
        "id": "ContribRoleID193",
        "type": "ContributoryRole",
        "label": "assessor role"
      }
    }
  ]
}
